Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
Ipilimumab
×
Dermatologic
×
Clear all
Filters
3
NCT01866319
2020-06-02
MK-3475-006
Merck Sharp & Dohme LLC
Phase 3
Completed
834 enrolled
13 charts